GIOVANNY NUNEZ: Open Payments
NPI 1760426118 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 140 payments from 14 companies in 2025. Trend: 2023 $2,670 · 2024 $2,098 · 2025 $2,639
Food & beverage: $2,624Education: $15
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 23 | $474 |
| Vanda Pharmaceuticals Inc. | 20 | $394 |
| ABBVIE INC. | 17 | $374 |
| E.R. Squibb & Sons, L.L.C. | 14 | $340 |
| Otsuka America Pharmaceutical, Inc. | 28 | $335 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $284 |
| Lundbeck LLC | 13 | $233 |
| ACADIA Pharmaceuticals Inc | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: Auvelity, REXULTI, HETLIOZ, COBENFY, TRINTELLIX, VRAYLAR, ABILIFY ASIMTUFII, QULIPTA.
Industry payments across NY — which companies pay providers there.
